Secretoneurin is not associated with cardiovascular events or mortality in patients treated with hemodialysis: A prospective multicenter cohort study
Patients treated with HD have high SN concentrations; however, SN was not associated with CV events or all-cause mortality after five years of follow-up. High concentrations of SN, possibly explained by both impaired renal clearance and a high prevalence of cardiomyopathy, may limit its prognostic relevance in patients treated with maintenance HD.
Authors
- Caroline Hundborg Liboriussen
- Helge Rørvik Røsjø (ORCID: https://orcid.org/0000-0003-2114-3134)
- Rie Io Glerup
- My Svensson (ORCID: https://orcid.org/0000-0002-6812-9789)
- Louis Nygaard (ORCID: https://orcid.org/0000-0003-1943-0097)
- Torbjørn Omland (ORCID: https://orcid.org/0000-0002-6452-0369)
- Magnus Nakrem Lyngbakken (ORCID: https://orcid.org/0000-0002-5994-9304)
- Jens Dam Jensen
- Sara Marie Engelsvold Bakkan
Institutions
- Oslo University Hospital (NO)
- University of Oslo (NO)
- Aalborg University Hospital (DK)
- Akershus University Hospital (NO)
- Aalborg University (DK)
Publication Details
- Journal
- Clinical Biochemistry
- Published
- 2025-02-21
- DOI
- https://doi.org/10.1016/j.clinbiochem.2025.110899
- Primary Topic
- Neonatal and fetal brain pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Lundbeckfonden
- Karen Elise Jensens Fond
- Dansk Nefrologisk Selskab
- Nyreforeningen
- Det Obelske Familiefond
- Spar Nord Fonden
- H. Lundbeck A/S
- Helen og Ejnar Bjørnows Fond